Caribou Biosciences (CRBU) Interest & Investment Income (2020 - 2026)
Caribou Biosciences' (CRBU) quarterly Interest & Investment Income came in at -$126000.0 in Q1 2026, down 43.18% year-on-year from -$221760.0 in Q1 2025, and down 1360.0% on a QoQ basis from $10000.0 in Q4 2025.
Caribou Biosciences (CRBU) Interest & Investment Income (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of Interest & Investment Income data on file, last reported at -$126000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 43.18% year-over-year to -$126000.0 in Q1 2026; TTM through Mar 2026 was -$190000.0, a 138.85% decrease from a year earlier, with the FY2025 full-year figure at -$152000.0, down 167.56% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$126000.0, down from $10000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for CRBU reached as high as $1.1 million in Q3 2024 and fell as low as -$954000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $6588.2 across 5 years, with a median of -$88000.0 in 2025.
- Across the five-year window, Interest & Investment Income jumped 614.84% in 2024 and slumped 4333.33% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $517000.0 in 2022, then soared by 95.55% to $1.0 million in 2023, then slumped by 152.82% to -$534000.0 in 2024, then jumped by 101.87% to $10000.0 in 2025, then slumped by 1360.0% to -$126000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$126000.0 in Q1 2026, $10000.0 in Q4 2025, and $53000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Caribou Biosciences | 152.90 Mn | 35.27 Mn | - | -126,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | -127,000.00 |
| Mar 31, 2025 | -88,000.00 |
| Dec 31, 2024 | -534,000.00 |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | -352,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | -406,000.00 |
| Mar 31, 2023 | 788,000.00 |
| Dec 31, 2022 | 517,000.00 |
| Sep 30, 2022 | -454,000.00 |
| Jun 30, 2022 | -492,000.00 |
| Mar 31, 2022 | -954,000.00 |
| Dec 31, 2021 | -135,000.00 |
| Jun 30, 2021 | 46,000.00 |
| Dec 31, 2020 | 79,000.00 |